Sage Therapeutics, Inc. - COM (SAGE)

Q4 2023 13F Holders as of 12/31/2023

Type / Class
Equity / COM
Number of holders
197
Total Shares
56.1M
Shares change
-2.61M
Total reported value, excl. options
$1.22B
Value change
-$53.6M
Put/Call ratio
0.6
Number of buys
74
Number of sells
-105
Price
$21.67
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.